Cargando…
The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus
BACKGROUND: Group B streptococcus (GBS) is a leading cause of sepsis, pneumonia and meningitis in infants, with long term neurodevelopmental sequelae. GBS may be associated with poor pregnancy outcomes, including spontaneous abortion, stillbirth and preterm birth. Intrapartum antibiotic prophylaxis...
Autores principales: | Berardi, Alberto, Cassetti, Tiziana, Creti, Roberta, Vocale, Caterina, Ambretti, Simone, Sarti, Mario, Facchinetti, Fabio, Cose, Stephen, Heath, Paul, Le Doare, Kirsty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594470/ https://www.ncbi.nlm.nih.gov/pubmed/33115542 http://dx.doi.org/10.1186/s13052-020-00923-3 |
Ejemplares similares
-
A Vaccine Against Group B Streptococcus: Recent Advances
por: Carreras-Abad, Clara, et al.
Publicado: (2020) -
Seroepidemiology of maternally-derived antibody against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda - PROGRESS GBS
por: Kyohere, Mary, et al.
Publicado: (2020) -
Uncertainties in Screening and Prevention of Group B Streptococcus Disease
por: Le Doare, Kirsty, et al.
Publicado: (2019) -
Group B streptococcus late-onset disease,contaminated breast milk and mothers persistently GBS negative: report of 3cases
por: Nicolini, Giangiacomo, et al.
Publicado: (2018) -
Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel
por: Foschi, Claudio, et al.
Publicado: (2021)